Early research (Phase 1)Not Yet RecruitingNCT06770504
What this trial is testing
YTS109 Cell Injection in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia
Who this might be right for
Autoimmune Hemolytic AnemiaAnti-CD19 STAR T-cell TherapyFailure ≥3 Lines of Therapies
Institute of Hematology & Blood Diseases Hospital, China 7